AZN ASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 85.12 $ 0.61 (0.72 %)    

Tuesday, 14-Oct-2025 15:59:58 EDT
QQQ $ 598.05 $ -4.01 (-0.67 %)
DIA $ 462.92 $ 2.03 (0.44 %)
SPY $ 662.14 $ -0.81 (-0.12 %)
TLT $ 90.68 $ 0.29 (0.32 %)
GLD $ 381.35 $ 2.70 (0.71 %)
$ 85.12
$ 84.55
$ 84.00 x 11
$ 85.03 x 1
$ 84.30 - $ 85.17
$ 60.82 - $ 86.57
4,885,986
na
131.99B
$ 0.46
$ 7.29
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hedge-fund-shah-capital-urges-novavax-to-consider-sale-amid-vaccine-rollout-struggles-sees-5-billion-potential

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least...

 astrazeneca-opens-expanded-manufacturing-facility-in-coppell-texas

AstraZeneca (NASDAQ:AZN) opened its expanded manufacturing facility in Coppell, Texas, following a $445 million investment to d...

 astrazeneca-advances-ambition-to-redefine-cancer-care-with-new-data-across-diverse-portfolio-and-pipeline-at-esmo-congress-october-17-21

Presidential Symposium will feature DESTINY-Breast11 and DESTINY-Breast05, underscoring potential of ENHERTU® (fam-trastuzumab ...

 astrazeneca-ceo-soriot-says-negotiated-3-year-tariff-exemption-with-trump-administration

https://www.youtube.com/watch?v=XOtOCzut9pM

Core News & Articles

https://www.youtube.com/watch?v=XOtOCzut9pM

Core News & Articles

https://www.youtube.com/watch?v=XOtOCzut9pM

 trump-plans-astrazeneca-deal-to-cut-drug-prices-for-low-income-americans

Trump to announce new deal with AstraZeneca to lower prescription drug costs for Americans using most-favored-nation pricing mo...

 trump-strikes-drug-pricing-deal-with-pharma-giant-astrazeneca--msnbc

https://www.msnbc.com/msnbc/news/trump-strikes-drug-pricing-deal-pharma-giant-astrazeneca-rcna236905

 uk-weighs-25-rise-in-drug-prices-as-pharma-giants-pause-investments

UK ministers consider raising NHS drug spending by up to 25% amid pharma investment delays and pressure from US pricing policies.

 astrazeneca-expands-virginia-investment-to-45-billion-for-cancer-obesity-drugs

AstraZeneca will invest $4.5 billion in a Virginia facility, creating 3,600 jobs and producing advanced cancer and metabolic me...

 trump-administration-engages-pharmacies-goodrx-for-trumprx-launch

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S. consumers.

 astrazeneca-to-invest-45b-in-new-virginia-facility-as-part-of-50b-investment-announced-in-july-2025-to-create-3700-new-jobs

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a bro...

 astrazenecas-baxdrostat-shows-meaningful-blood-pressure-control-in-patients-with-resistant-hypertension

AstraZeneca's Baxdrostat cut 24-hour systolic blood pressure in a Phase 3 trial, showing promise for treatment-resistant hy...

 astrazeneca-says-high-level-results-from-bax24-phase-3-trial-showed-baxdrostat-demonstrated-a-statistically-significant-and-highly-clinically-meaningful-reduction-in-ambulatory-24-hour-average-systolic-blood-pressure-compared-with-placebo-at-12-weeks

Patients with treatment-resistant hypertension (rHTN) received baxdrostat 2mg or placebo on top of standard of care. Baxdrostat...

 amgen-to-offer-cholesterol-drug-at-60-discount-as-trump-administrations-call-to-lower-drug-prices

Amgen launches AmgenNow, offering Repatha at $239 per month, expanding direct access for U.S. patients with no insurer restrict...

 astrazeneca-taps-gene-editing-and-ai-platform-for-drug-discovery-for-immunology-diseases

Algen Biotechnologies partners with AstraZeneca in a $555 million deal to advance AI-driven CRISPR drug discovery and novel imm...

 astrazenecadaiichi-sankyo-partnered-breast-cancer-drug-shows-survival-benefit-over-chemotherapy

AstraZeneca and Daiichi Sankyo's Datroway improved survival outcomes over chemotherapy in advanced triple-negative breast c...

 financial-times-reported-astrazeneca-signs-555m-ai-deal-to-develop-gene-editing-therapies

https://www.ft.com/content/c4b5153f-be07-454d-911f-31bb011f09ae

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION